BioSpace News Archive

BioMarin Pharmaceutical Inc. announced that the U.S. Food and Drug Administration has accepted the New Drug Application for vosoritide, an investigational, once daily injection analog of C-type Natriuretic Peptide for children with achondroplasia, the most common form of disproportionate short stature in humans.

The sites at the first two local health districts in NSW Health Care are now live with international medical imaging IT and cybersecurity company Sectra’s radiology imaging solution.

Calithera Biosciences, Inc. announced that the compensation committee of the company’s board of directors granted three new employees non-qualified stock options to purchase an aggregate of 138,500 shares of Calithera’s common stock, at a per share exercise price of $3.54, the closing trading price on October 30, 2020.

Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following virtual conferences:

Bruker Corporation announced financial results for its third quarter and for the nine months ended September 30, 2020.

Owens & Minor, Inc. reported financial results for the third quarter of 2020, as summarized in the table below.

Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following virtual investor conferences in November

STERIS plc announced financial results for its fiscal 2021 second quarter ended September 30, 2020.

ImmunoGen, Inc. announced that on October 30, 2020 the compensation committee of the Company’s Board of Directors granted a non-qualified stock option award to purchase an aggregate of 21,500 shares of its common stock to a new employee under the ImmunoGen, Inc.

3D-printed anatomical models replicate biomechanics of human anatomy to help improve training, transform surgical planning and bring new medical innovations to market faster